|
Name |
Tensyuic acid C
|
Molecular Formula | C13H20O6 | |
IUPAC Name* |
2-(6-ethoxy-6-oxohexyl)-3-methylidenebutanedioic acid
|
|
SMILES |
CCOC(=O)CCCCCC(C(=C)C(=O)O)C(=O)O
|
|
InChI |
InChI=1S/C13H20O6/c1-3-19-11(14)8-6-4-5-7-10(13(17)18)9(2)12(15)16/h10H,2-8H2,1H3,(H,15,16)(H,17,18)
|
|
InChIKey |
STUMFFBVBKIJSG-UHFFFAOYSA-N
|
|
Synonyms |
Tensyuic acid C; (-)-tensyuic acid C; CHEBI:133829; (-)-2-(6-ethoxy-6-oxohexyl)-3-methylenesuccinic acid; 2-(6-ethoxy-6-oxohexyl)-3-methylidenebutanedioic acid; (-)-2-(6-ethoxy-6-oxohexyl)-3-methylidenebutanedioic acid; (2Xi)-2-(6-ethoxy-6-oxohexyl)-3-methylenesuccinic acid; (2Xi)-2-(6-ethoxy-6-oxohexyl)-3-methylidenebutanedioic acid
|
|
CAS | NA | |
PubChem CID | 17757653 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 272.29 | ALogp: | 1.9 |
HBD: | 2 | HBA: | 6 |
Rotatable Bonds: | 11 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 101.0 | Aromatic Rings: | 0 |
Heavy Atoms: | 19 | QED Weighted: | 0.36 |
Caco-2 Permeability: | -5.775 | MDCK Permeability: | 0.00378713 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.015 | 20% Bioavailability (F20%): | 0.003 |
30% Bioavailability (F30%): | 0.645 |
Blood-Brain-Barrier Penetration (BBB): | 0.347 | Plasma Protein Binding (PPB): | 75.16% |
Volume Distribution (VD): | 0.274 | Fu: | 24.08% |
CYP1A2-inhibitor: | 0.008 | CYP1A2-substrate: | 0.066 |
CYP2C19-inhibitor: | 0.025 | CYP2C19-substrate: | 0.051 |
CYP2C9-inhibitor: | 0.002 | CYP2C9-substrate: | 0.9 |
CYP2D6-inhibitor: | 0.017 | CYP2D6-substrate: | 0.091 |
CYP3A4-inhibitor: | 0.016 | CYP3A4-substrate: | 0.008 |
Clearance (CL): | 6.326 | Half-life (T1/2): | 0.889 |
hERG Blockers: | 0.004 | Human Hepatotoxicity (H-HT): | 0.082 |
Drug-inuced Liver Injury (DILI): | 0.075 | AMES Toxicity: | 0.003 |
Rat Oral Acute Toxicity: | 0.039 | Maximum Recommended Daily Dose: | 0.004 |
Skin Sensitization: | 0.418 | Carcinogencity: | 0.023 |
Eye Corrosion: | 0.984 | Eye Irritation: | 0.97 |
Respiratory Toxicity: | 0.044 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002150 | 0.679 | D0E4WR | 0.349 | ||||
ENC002268 | 0.638 | D0G2KD | 0.333 | ||||
ENC003534 | 0.408 | D0AY9Q | 0.333 | ||||
ENC000543 | 0.394 | D05PHH | 0.310 | ||||
ENC000248 | 0.391 | D0Z0MG | 0.297 | ||||
ENC000758 | 0.386 | D07JVS | 0.293 | ||||
ENC003189 | 0.369 | D02GIU | 0.284 | ||||
ENC001015 | 0.362 | D00MLW | 0.276 | ||||
ENC001287 | 0.361 | D0FD0H | 0.276 | ||||
ENC001325 | 0.352 | D02HFD | 0.275 |